Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

August 23, 2021

Jason Klimek Joins Barclay Damon

August 23, 2021—Barclay Damon announces Jason Klimek, special counsel, has joined Barclay Damon’s Cannabis Team and Corporate Practice Area. His primary office location is Rochester.

Klimek is the co-leader of the firm’s Cannabis Team. He primarily concentrates his practice on the nuanced processes of structuring, licensing, and maintaining compliant cannabis businesses at the federal, state, and local levels. He has extensive experience advising clients, including cannabis companies, startups, small to midsize technology companies, and medical professionals, on various complex federal and state tax compliance issues affecting cannabis-touching businesses as well as entity selection, funding, intellectual property, employment matters, and securities transactions.

Klimek is a member of the New York State Bar Association Committee on Cannabis Law. He also serves as the New York State Bar Association Committee on Cannabis Law Tax Section liaison.

Barclay Damon attorneys team across offices and practices to provide customized, targeted solutions grounded in industry knowledge and a deep understanding of our clients’ businesses. With nearly 300 attorneys, Barclay Damon is a leading law firm that operates from a strategic platform of offices located in the Northeastern United States and Toronto. For more information, visit our award-winning website at www.barclaydamon.com.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Massachusetts Federal Court Permits Sharing Clause in Protective Order in Products Liability Case

Alerts

NYS Court of Appeals Holds That Parent May Not Recover for Emotional Injuries in Prenatal-Injury Case

Alerts

Smarter Inventory Management for Pharmacies: Navigating Online Marketplace Compliance

Alerts

Emergency Wine Run, Now Legal: New York State Opens Retail-to-Retail Sales

Alerts

California's Updated Privacy Regulations: Automated Decisionmaking Technology, Cybersecurity Audits, and Risk Assessments, Part 1

Alerts

Pharmacies on High Alert: Optum Rx's 25-Percent Therapeutic-Class Cap Creates Major Legal, Operational, and Competitive Risks